These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 401681)

  • 1. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to tumor growth mediated by Listeria monocytogenes. Destruction of experimental malignant melanoma by LM-activated peritoneal and lymphoid cells.
    Youdim S
    J Immunol; 1976 Mar; 116(3):579-84. PubMed ID: 56396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to tumor growth mediated by Listeria monocytogenes: collaborative and suppressive macrophage-lymphocyte interactions in vitro.
    Youdim S; Sharman M
    J Immunol; 1976 Nov; 117(5 Pt.2):1860-5. PubMed ID: 825574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes.
    Finke JH; Sharma SD; Scott JW
    J Immunol; 1981 Dec; 127(6):2354-61. PubMed ID: 6795272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS; Hodes RJ
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
    Igarashi T; Okada M; Kishimoto T; Yamamura Y
    J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity.
    Youdim
    Cancer Res; 1977 Apr; 37(4):991-6. PubMed ID: 403003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity mediated by soluble macrophage product(s).
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between subpopulations of normal mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity specific for "modified self" antigens.
    Hodes RJ; Hathcock KS; Shearer GM
    J Immunol; 1975 Oct; 115(4):1122-5. PubMed ID: 51877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
    Igarashi T; Rodrigues D; Ting CC
    J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
    Treves AJ; Schechter B; Cohen IR; Feldman M
    J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.